KURA - Kura Oncology, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 20.63

Open

$ 20.68

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 20.29 - $ 20.91

52 Week Range

$ 7.41 - $ 24.17

Volume

605,625

Average Volume

Market Cap

1.73B

Beta (5Y Monthly)

$ 1.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-04-2020	03-31-2020	10-Q
18	02-25-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	03-05-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-06-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-07-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-14-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-10-2016	06-30-2016	10-Q
33	05-11-2016	03-31-2016	10-Q
34	03-17-2016	12-31-2015	10-K
35	11-13-2015	09-30-2015	10-Q
36	08-14-2015	06-30-2015	10-Q
37	05-13-2015	03-31-2015	10-Q
38	02-27-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Kura...
05/03/2024 19:53:40

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $32 price t...

Wedbush Reiterates Outperform on Kura Onco...
05/03/2024 13:42:40

Wedbush analyst Robert Driscoll reiterates Kura Oncology (NASDAQ:KURA) with a Outperform and maintains $37 price target.

Kura Oncology Q1 2024 GAAP EPS $(0.59) Mis...
05/02/2024 20:19:33

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.5...

HC Wainwright & Co. Reiterates Buy on Kura...
04/22/2024 17:45:18

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $32 price t...

$kura-oncologys-ziftomenib-has-been-granted-fda-breakthrough-therapy-designation-for-relapsedrefractory-npm1-mutant-acute-myeloid-leukemia$

Kura Oncology's Ziftomenib, Has Been Grant...
04/22/2024 11:32:03

HC Wainwright & Co. Reiterates Buy on Kura...
03/06/2024 17:01:44

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $32 price t...

Kura Oncology Reports First Patient Dosed ...
03/06/2024 12:33:33

HC Wainwright & Co. Reiterates Buy on Kura...
02/28/2024 18:31:55

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $32 price t...

Wedbush Reiterates Outperform on Kura Onco...
02/28/2024 13:08:46

Wedbush analyst Robert Driscoll reiterates Kura Oncology (NASDAQ:KURA) with a Outperform and maintains $37 price target.

Kura Oncology: Q4 Earnings Insights
02/27/2024 21:30:33

Kura Oncology Q4 2023 GAAP EPS $(0.55) Mis...
02/27/2024 21:26:27

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.5...

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Earnings Outlook For Kura Oncology
02/26/2024 17:01:07

Kura Oncology Has Dosed The First Patient ...
02/26/2024 12:42:06

JMP Securities Maintains Market Outperform...
01/31/2024 18:34:32

JMP Securities analyst Reni Benjamin maintains Kura Oncology (NASDAQ:KURA) with a Market Outperform and raises the price tar...

why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why UPS Shares Are Trading Lower By 8%? He...
01/30/2024 18:18:27

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...

why-cancer-drug-developer-kura-oncology-stock-is-up

Why Cancer-Drug Developer Kura Oncology St...
01/30/2024 16:15:38

Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 pa...

General Motors Posts Upbeat Earnings, Join...
01/30/2024 15:09:58

U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday.

Kura Oncology Reports Preliminary Ziftomen...
01/30/2024 12:01:51

Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision m...

dow-edges-lower-us-composite-pmi-rises-in-january

Dow Edges Lower; US Composite PMI Rises In...
01/24/2024 20:46:28

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0...